Search results for “Tumor necrosis factor receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,299 patents, we discovered top 174 key players by total patent application. ZymoGenetics, Inc., Human Genome Sciences, Inc., Astute Medical, Inc. are dominant in this area. They take 20.40% of the total patent filing.
ZymoGenetics, Inc.
Washington, United States
Patent: 103
Human Genome Sciences, Inc.
United States
Patent: 82
Astute Medical, Inc.
California, United States
Patent: 80
Yeda Research & Development Co. Ltd.
Israel
Patent: 79
Bristol Myers Squibb Co.
New York, United States
Patent: 59
Amgen, Inc.
California, United States
Patent: 57
Inhibrx, Inc.
California, United States
Patent: 55
Immunex Corp.
Washington, United States
Patent: 49
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 43
Genentech, Inc.
California, United States
Patent: 39
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 53 patents, we discovered top 6 start-ups by total patent application. Eucure (Beijing) Biopharma Co., Ltd., Institut National de la Santé et de la Recherche Médicale, Inflazome Ltd. are active in this area.
STARTUP
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 34
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 9
STARTUP
Inflazome Ltd.
DUBLIN, Ireland
Patent: 4
STARTUP
Amathus Therapeutics, Inc.
Massachusetts, United States
Patent: 3
STARTUP
CoImmune, Inc.
North Carolina, United States
Patent: 2
STARTUP
Enosi Life Sciences Corp.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 343 patents applied in the last 5 years. We discover 100 most active companies in this area. The fast-growing Eucure (Beijing) Biopharma Co., Ltd., Inhibrx, Inc., Regeneron Pharmaceuticals, Inc. take 20.99% of patent filing during this period.
STARTUP
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 27
Inhibrx, Inc.
California, United States
Patent: 25
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 20
The General Hospital Corp.
Massachusetts, United States
Patent: 20
WuXi Biologics Ireland Ltd.
Ireland
Patent: 12
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 12
Bristol Myers Squibb Co.
New York, United States
Patent: 11
Evotec International GmbH
Hamburg, Germany
Patent: 8
Sanofi SA
France
Patent: 8
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 8
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 343 patents in last 5 years, we discover 67 new entrants. Iovance Biotherapeutics, Inc., WuXi Biologics Ireland Ltd., Sanofi SA are the most active new entrants in this area.
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 12
WuXi Biologics Ireland Ltd.
Ireland
Patent: 12
Sanofi SA
France
Patent: 8
Evotec International GmbH
Hamburg, Germany
Patent: 8
Biolojic Design Ltd.
Israel
Patent: 7
McMaster University
Ontario, Canada
Patent: 6
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 6
Universität Stuttgart
Baden-Württemberg, Germany
Patent: 6
University of the Ryukyus
Okinawa-ken, Japan
Patent: 5
Beijing VDJBio Co., Ltd.
Beijing Shi, China
Patent: 5
Research Institutions
Order by:
Innovation Intensity
With the analysis among 268 patents, we discovered top 50 universities and scientific research institutions by total patent application. University of Miami, The University of North Carolina at Chapel Hill, Yale University are dominant in this area. They take 37.31% of the total patent filing.
University of Miami
United States
Patent: 36
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 11
Yale University
Connecticut, United States
Patent: 6
McMaster University
Ontario, Canada
Patent: 6
Universität Stuttgart
Baden-Württemberg, Germany
Patent: 6
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 5
University of Huddersfield
United Kingdom
Patent: 5
Julius-Maximilians-Universität Würzburg
Bayern, Germany
Patent: 5
Mie University
Mie-ken, Japan
Patent: 5
University of the Ryukyus
Okinawa-ken, Japan
Patent: 5
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: